Bevacizumab reduces the growth rate constants of renal carcinomas: a novel algorithm suggests early discontinuation of bevacizumab resulted in a lack of survival advantage (Q35837560)
Jump to navigation
Jump to search
scientific article published on 30 September 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Bevacizumab reduces the growth rate constants of renal carcinomas: a novel algorithm suggests early discontinuation of bevacizumab resulted in a lack of survival advantage |
scientific article published on 30 September 2008 |
Statements
1 reference
Bevacizumab reduces the growth rate constants of renal carcinomas: a novel algorithm suggests early discontinuation of bevacizumab resulted in a lack of survival advantage (English)
1 reference
Susan E Bates
1 reference
Tito Fojo
1 reference
James Yang
1 reference
Wilfred D Stein
1 reference
30 September 2008
1 reference
1 reference
1055-1062
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference